TANG CAPITAL MANAGEMENT LLC - Q4 2016 holdings

$188 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 8 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 0.0% .

 Value Shares↓ Weighting
HRTX  HERON THERAPEUTICS INC$81,183,000
-24.0%
6,197,1980.0%43.30%
-2.2%
LJPC  LA JOLLA PHARMACEUTICAL CO$55,941,000
-26.3%
3,191,1650.0%29.83%
-5.3%
RXDX  IGNYTA INC$21,056,000
-15.7%
3,972,8000.0%11.23%
+8.3%
 OPKO HEALTH INCdebt 3.0% 2/1/33$19,355,000
-12.1%
14,000,0000.0%10.32%
+13.0%
BMRN  BIOMARIN PHARMACEUTICAL INC$7,473,000
-10.5%
90,2150.0%3.98%
+15.1%
CYCC  CYCLACEL PHARMACEUTICALS INC$1,904,000
-11.8%
359,9000.0%1.02%
+13.4%
LIFE  ATYR PHARMA INC$601,000
-32.4%
279,4250.0%0.32%
-13.0%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HERON THERAPEUTICS INC37Q3 202355.0%
LA JOLLA PHARMACEUTICAL CO34Q2 202237.1%
ROCKET PHARMACEUTICALS INC20Q3 202331.6%
BIOMARIN PHARMACEUTICAL INC18Q3 201712.1%
ODONATE THERAPEUTICS INC17Q4 202169.8%
ANAPTYSBIO INC16Q3 202318.4%
COHERUS BIOSCIENCES INC15Q3 20232.7%
EQUILLIUM INC13Q3 20231.2%
RELMADA THERAPEUTICS INC12Q4 20226.2%
MIRATI THERAPEUTICS INC11Q3 202310.9%

View TANG CAPITAL MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
42024-02-14
42024-02-02
42023-12-18
13F-HR2023-11-14
42023-10-13
13F-HR2023-08-14
32023-06-01
42023-06-01
42023-05-30

View TANG CAPITAL MANAGEMENT LLC's complete filings history.

Compare quarters

Export TANG CAPITAL MANAGEMENT LLC's holdings